GLP-1 Patches: An In-Depth, Non-Promotional Overview
Introduction Glucagon-like peptide-1 (GLP-1) has become a central topic in discussions around metabolic health, particularly in relation to type 2 diabetes, obesity, and appetite regulation. Traditionally, GLP-1–based therapies have been administered via injections or oral medications. More recently, interest has emerged around the idea of GLP-1 patches—transdermal systems designed to deliver GLP-1 or GLP-1–related compounds…